Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

33.93
Delayed Data
As of Dec 02
 +0.38 / +1.13%
Today’s Change
30.89
Today|||52-Week Range
59.00
-41.58%
Year-to-Date
Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile
Nov 30 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for November 28th
Nov 28 / Zacks.com - Paid Partner Content
3 High-Yield Dividend Stocks to Buy in December
Nov 30 / MotleyFool.com - Paid Partner Content
Novo Nordisk's Diabetes Combination Drug Gets FDA's Nod
Nov 23 / Zacks.com - Paid Partner Content